All Updates

All Updates

icon
Filter
M&A
Thermo Fisher Scientific to absorb Swedish proteomics player Olink in USD 3.1 billion deal
Precision Medicine
Oct 17, 2023
This week:
Funding
MeliBio receives strategic investment from Future Food Fund
Alternative Ingredients
Yesterday
Product updates
Catchfree launches microalgae-based shrimp alternative
Plant-based Meat
Yesterday
Product updates
AQUA Cultured Foods introduces fermentation-based raw tuna alternative
Plant-based Meat
Yesterday
Management news
SDI Element Logic rebrands as Element Logic
Logistics Tech
Yesterday
Geographic expansion
Wayve opens office and commences testing of automated driving features in US
Auto Tech
Yesterday
Partnerships
Qualcomm and Google partner to develop AI-driven automotive solutions
Auto Tech
Yesterday
Product updates
Meta AI releases LayerSkip to accelerate inference in LLMs
Generative AI Infrastructure
Yesterday
Funding
Freeform secures funding from NVIDIA's NVentures
Additive Manufacturing
Oct 22, 2024
Product updates
Flexxbotics announces compatibility with LMI Technologies for quality inspection
Smart Factory
Oct 22, 2024
Funding
Oxla raises USD 11 million in seed funding to drive commercialization
Data Infrastructure & Analytics
Oct 22, 2024
Precision Medicine

Precision Medicine

Oct 17, 2023

Thermo Fisher Scientific to absorb Swedish proteomics player Olink in USD 3.1 billion deal

M&A

  • Thermo Fisher Scientific (Thermo) has offered to acquire Olink, a Swedish provider of proteomics analysis equipment and services for tracking down and developing biomarkers.

  • Through a deal worth USD 3.1 billion, Thermo has agreed to pay USD 26 for each of Olink’s shares. Olink has around USD 143 million cash in hand, alongside the company’s international operations in Boston, Tokyo, and Shanghai. The acquisition is intended to extend Thermo’s reach in protein research.

  • Thermo is a provider of medical equipment, analytical instruments, reagents and consumables, software, and services to tackle complex analytical challenges in research, diagnostics, and clinical laboratories. It offers solutions for cellular analysis and biology, flow cytometry, and synthetic biology. The company has a range of products, which include technologies for mass spectrometry, genetic sequencing, electron microscopy, protein, and molecular biology research.

  • Olink develops and markets its unique technology for protein analysis in human protein biomarker research. Olink’s proprietary Proximity Extension Assay (PEA) technology enables researchers to analyze large numbers of proteins with high-throughput analysis, exceptional data quality, and minimal sample consumption.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.